1. Home
  2. GILD vs TXN Comparison

GILD vs TXN Comparison

Compare GILD & TXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gilead Sciences Inc.

GILD

Gilead Sciences Inc.

N/A

Current Price

$169.77

Market Cap

211.7B

Sector

Health Care

ML Signal

N/A

Logo Texas Instruments Incorporated

TXN

Texas Instruments Incorporated

N/A

Current Price

$310.56

Market Cap

270.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GILD
TXN
Founded
1987
1930
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
211.7B
270.4B
IPO Year
2003
2003

Fundamental Metrics

Financial Performance
Metric
GILD
TXN
Price
$169.77
$310.56
Analyst Decision
Buy
Buy
Analyst Count
28
35
Target Price
$174.77
★ $336.86
AVG Volume (30 Days)
6.4M
★ 7.9M
Earning Date
10-29-2026
10-21-2026
Dividend Yield
1.92%
★ 2.02%
EPS Growth
★ 1684.21
4.81
EPS
N/A
★ 6.44
Revenue
★ $24,689,000,000.00
$17,682,000,000.00
Revenue This Year
$6.52
$26.68
Revenue Next Year
$7.05
$17.32
P/E Ratio
★ N/A
$46.61
Revenue Growth
9.98
★ 13.05
52 Week Low
$116.88
$152.73
52 Week High
$176.58
$334.03

Technical Indicators

Market Signals
Indicator
GILD
TXN
Relative Strength Index (RSI) 62.45 59.06
Support Level $142.91 $273.89
Resistance Level N/A $314.28
Average True Range (ATR) 4.68 12.71
MACD 0.32 -0.28
Stochastic Oscillator 67.12 85.45

Price Performance

Historical Comparison
GILD
TXN

About GILD Gilead Sciences Inc.

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

About TXN Texas Instruments Incorporated

Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.

Share on Social Networks: